Mechanistically, obesity exacerbates tumor progression through hormonal imbalance, chronic inflammation, and adipokine and insulin signaling, targets that may be modifiable through weight reduction. The gene discussed is INS; the disease is obesity due to melanocortin 4 receptor deficiency.